Drug Pipeline

GVHD Prophylaxis Clinical Trials

Name: GVHD Prophylaxis clinical trials — 4 active studies
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12

Active Studies

Recruiting

Top Sponsors

Changes, 30 Days

What Changed in the Last 30 Days

Detected	Trial	Change
2026-06-06	NCT03922724 Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma	date change Primary completion pushed: 2026-10-31 -> 2027-06-01

Active Studies by Phase

Phase 2

Phase 1/2

Active Trials

NCT ID	Title	Condition	Status
Phase 2
NCT02579967	Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies	Primary T-cell Immunodeficiency Disorders	Recruiting
NCT03922724	Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma	Peripheral T-cell Lymphomas	Recruiting
NCT03663933	Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation…	Lymphoproliferative Disorders	Active, Not Recruiting
Phase 1/2
NCT05470491	Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell…	HIV	Recruiting

Sponsors Running GVHD Prophylaxis Trials

National Cancer Institute (NCI) (4)

Get alerts when GVHD Prophylaxis trials change

Status changes, date slips, and new filings — detected daily, delivered to your inbox.